| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.07 | 0.8 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |